3-Acetoxy-8(17),13E-labdadien-15-oic acid

3-Acetoxy-8(17),13E-labdadien-15-oic acid
Product Name 3-Acetoxy-8(17),13E-labdadien-15-oic acid
CAS No.: 63399-37-1
Catalog No.: CFN97090
Molecular Formula: C22H34O4
Molecular Weight: 362.5 g/mol
Purity: >=98%
Type of Compound: Diterpenoids
Physical Desc.: Powder
Targets: Calcium Channel | cAMP | Potassium Channel | NO
Source: The rhizomes of Cibotium barometz (L.) J.Sm.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price:
ent-3-Acetoxy-labda-8(17),13-dien-15-oic acid have vasorelaxant and hypotensive actions, the mechanisms underlying the cardiovascular actions of the labdane involve the activation of the endothelial NO-cGMP pathway, the opening of K+ channels and the alteration on Ca2+ mobilization.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Cell Mol Med . 2023, jcmm.17954.
  • J Appl Pharm Sci.2022, 12(04):044-053
  • J Appl Microbiol.2022, 132(2):949-963.
  • Food Chem.2023, 424:136383.
  • J Ethnopharmacol.2017, 206:73-77
  • Biomol Ther (Seoul).2020, 28(6):542-548.
  • Phytomedicine.2019, 55:229-237
  • Journal of Oil Palm Research2019, 31(2):238-247
  • Anat Rec2018, 24264
  • J Enzyme Inhib Med Chem.2019, 34(1):134-143
  • ent-14,15-Dinor-13-oxolabda-8(17),11-dien-18-oic acid

    Catalog No: CFN97440
    CAS No: 875585-30-1
    Price: Inquiry(manager@chemfaces.com)
    Coronadiene

    Catalog No: CFN92778
    CAS No: 1145689-64-0
    Price: Inquiry(manager@chemfaces.com)
    15-Nor-14-oxolabda-8(17),12-dien-18-oic acid

    Catalog No: CFN99058
    CAS No: 1039673-32-9
    Price: Inquiry(manager@chemfaces.com)
    Junicedric acid

    Catalog No: CFN89382
    CAS No: 41787-69-3
    Price: Inquiry(manager@chemfaces.com)
    Zerumin A

    Catalog No: CFN92779
    CAS No: 176050-48-9
    Price: Inquiry(manager@chemfaces.com)
    Alepterolic acid

    Catalog No: CFN97091
    CAS No: 63399-38-2
    Price: Inquiry(manager@chemfaces.com)
    3-Acetoxy-8(17),13E-labdadien-15-oic acid

    Catalog No: CFN97090
    CAS No: 63399-37-1
    Price: Inquiry(manager@chemfaces.com)
    ent-3beta,18-Dihydroxylabda-8(17),13E-dien-15-oic acid

    Catalog No: CFN89391
    CAS No: 99624-39-2
    Price: Inquiry(manager@chemfaces.com)
    9-Hydroxy-13E-labden-15-oic acid

    Catalog No: CFN99412
    CAS No: 132915-47-0
    Price: Inquiry(manager@chemfaces.com)
    Coronarin B

    Catalog No: CFN99303
    CAS No: 119188-38-4
    Price: Inquiry(manager@chemfaces.com)
    Eur J Pharmacol. 2014 Mar 5;726:66-76.
    Mechanisms underlying the vascular and hypotensive actions of the labdane ent-3-acetoxy-labda-8(17),13-dien-15-oic acid.[Pubmed: 24463178 ]
    We investigated the mechanisms underlying the vasorelaxant and hypotensive actions of the labdane-type diterpene ent-3-acetoxy-labda-8(17),13-dien-15-oic acid (3-Acetoxy-8(17),13E-labdadien-15-oic acid,labda-15-oic acid).
    METHODS AND RESULTS:
    Vascular reactivity experiments were performed in aortic rings isolated from male Wistar rats. cAMP and cGMP were measured by enzyme immunoassay (EIA) whereas nitrate measurement was performed by chemiluminescence. Nitric oxide (NO) concentration ([NO]c) was measured in endothelial cells by flow cytometry. The cytosolic calcium concentration ([Ca2+]c) in vascular smooth muscle cells (VSMC) was measured by confocal microscopy. Blood pressure measurements were performed in conscious rats. Labda-15-oic acid inhibited the contraction induced by phenylephrine and serotonin in either endothelium-intact or endothelium-denuded rat aortic rings. The labdane significantly reduced CaCl2-induced contraction in a Ca2+-free solution containing KCl or phenylephrine. Labda-15-oic acid (0.1–300 μmol/l) concentration-dependently relaxed endothelium-intact and endothelium-denuded aortas pre-contracted with either phenylephrine or KCl. In endothelium-intact rings, the relaxation induced by labda-15-oic acid was affected by L-NAME, 7-nitroindazole, ODQ, hemoglobin, Rp-8-Br-Pet-cGMPS and thapsigargin. Blockade of K+ channels with 4-aminopyridine, apamin, charybdotoxin and glibenclamide affected the relaxation induced by labda-15-oic acid. The labdane increased cGMP and nitrate levels but did not affect cAMP levels in endothelium-intact aortas. Labda-15-oic acid increased [NO]c in endothelial cells and decreased [Ca2+]c in VSMC. The hypotension induced by intravenous administration of labda-15-oic acid (0.3–3 mg/kg) was partially reduced by L-NAME.
    CONCLUSIONS:
    In conclusion, the mechanisms underlying the cardiovascular actions of the labdane involve the activation of the endothelial NO-cGMP pathway, the opening of K+ channels and the alteration on Ca2+ mobilization.
    Arjungenin

    Catalog No: CFN95039
    CAS No: 58880-25-4
    Price: $318/20mg
    Kaempferol 3-O-beta-(6''-p-coumaroyl)glucopyranosyl(1->2)-alpha-L-rhamnopyranoside

    Catalog No: CFN95089
    CAS No: 111957-48-3
    Price: $338/10mg
    Maculosidin

    Catalog No: CFN95126
    CAS No: 522-19-0
    Price: $413/5mg
    Kaempferol 3,4'-di-O-glucoside

    Catalog No: CFN95357
    CAS No: 71939-16-7
    Price: $318/5mg
    Toddalolactone 3'-O-methyl ether (6-(2-Hydroxy-3-methoxy-3-methylbutyl)-5,7-dimethoxycoumarin)

    Catalog No: CFN95372
    CAS No: 143614-35-1
    Price: $318/10mg
    New compound 14

    Catalog No: CFN95381
    CAS No: N/A
    Price: $413/5mg
    3',8-Dihydroxyvestitol

    Catalog No: CFN95384
    CAS No: 122587-87-5
    Price: $413/5mg
    Crepidiaside B

    Catalog No: CFN95432
    CAS No: 101921-35-1
    Price: $318/10mg
    Ganoderic acid GS-3

    Catalog No: CFN95518
    CAS No: 1206781-66-9
    Price: $413/5mg
    1-O-Feruloylglucose

    Catalog No: CFN95596
    CAS No: 64625-37-2
    Price: $413/5mg